Treatment of Congenital Afibrinogenemia in a Neonate With Critical Pulmonary Stenosis.

J Pediatr Pharmacol Ther

Division of Pediatric Hematology/Oncology (PP, TLL), UCSF Benioff Children's Hospital, San Francisco, CA.

Published: June 2023

Fibrinogen deficiencies in neonates can lead to bleeding complications. In this report, we describe a case of congenital afibrinogenemia in a newborn with critical pulmonary stenosis who presented with bilateral cephalohematomas after an uncomplicated delivery. The initial use of cryoprecipitate was followed by administration of fibrinogen concentrate. We estimated a half-life of 24 to 48 hours with the concentrate product. This patient received fibrinogen replacement and had a subsequent successful cardiac repair. The drug's shorter half-life in this neonate contrasts with prior reports of longer half-life in older patients and is important to note in treating future neonatal patients with this diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249975PMC
http://dx.doi.org/10.5863/1551-6776-28.3.268DOI Listing

Publication Analysis

Top Keywords

congenital afibrinogenemia
8
critical pulmonary
8
pulmonary stenosis
8
treatment congenital
4
afibrinogenemia neonate
4
neonate critical
4
stenosis fibrinogen
4
fibrinogen deficiencies
4
deficiencies neonates
4
neonates lead
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!